Dr. Reddy's Laboratories (RDY) announced that it has launched Clopidogrel Tablets, USP75 mg & 300 mg, a bioequivalent generic version of PLAVIX, in the U.S. market on May 18, 2012. The ANDAs for Clopidogrel Tablets USP,75 mg & 300 mg are approved by the United States Food & Drug Administration, or FDA.
Dr. Reddy's Clopidogrel Tablets USP, 75 mg are available in bottle count sizes of 30, 90 and 500, and Clopidogrel Tablets USP, 300 mg are available in blister packs of 30's count.
For comments and feedback: editorial@rttnews.com